冠心病诊断影像设备市场、机会、成长动力、产业趋势分析与预测，2024-2032

Coronary Heart Disease Diagnostic Imaging Devices Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月29日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2022 年，全球冠心病诊断影像设备市场份额达到18 亿美元，在冠心病(CHD) 患病率不断上升以及对早期诊断和诊断的需求不断增长的推动下，2024 年至2032 年期间将呈现6.6 % 的成长率。随着全球冠心病发病率上升，越来越需要先进的影像技术来早期检测病情。早期诊断可以及时干预，降低严重后果的风险。对主动医疗保健的关注推动了对复杂诊断影像设备的需求，从而扩大了市场，因为医疗保健系统优先考虑有效的早期检测解决方案。

整个冠心病诊断影像设备产业根据模式、应用、最终用途和地区进行细分。

由于其卓越的成像能力和精度，到 2032 年，电脑断层扫描 (CT) 领域将累积 4.438 亿美元的收入。 CT 扫描可提供心臟和血管的详细横断面影像，从而能够准确诊断冠状动脉疾病并评估斑块形成。该技术能够快速产生高解析度影像，使其成为寻求可靠、高效诊断工具的临床医生的首选。随着对详细心臟影像的需求增加，CT 领域将主导市场。

由于紧急情况下对快速、准确诊断的迫切需求，心臟病发作领域在 2023 年收入达 5.857 亿美元。及时识别心臟病发作对于有效治疗和改善患者预后至关重要。 CT 和 MRI 等诊断影像设备在评估心臟损伤程度和指导介入措施方面发挥关键作用。随着心臟病发病率持续上升，该领域对先进影像解决方案的需求将推动市场显着成长。

由于其先进的医疗基础设施、冠心病的高盛行率以及对医疗技术的大量投资，到2032年，美国冠心病诊断影像设备市场将达到13亿美元。该国强大的医疗保健系统和尖端诊断工具（包括先进的成像技术）的高采用率推动了市场成长。此外，美国受益于持续的研发工作，使其成为冠心病诊断成像设备产业扩张和创新的关键贡献者。

产业生态系统分析
产业影响力
- 成长动力
  - 冠心病患病率增加
  - 诊断影像技术的进步
  - 提高对冠心病的认识和早期诊断
  - 对非侵入性诊断工具的需求不断增长
- 产业陷阱与挑战
  - 成像设备成本高
  - 缺乏熟练的专业人员
成长潜力分析
监管环境
技术景观
- 核心技术
- 邻近技术
差距分析
未来市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按模式，2021 - 2032 年

主要趋势
电脑断层扫描 (CT)
X射线
超音波
磁振造影（MRI）
核子医学

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
心律不整
心臟病发作
心臟衰竭
先天性心臟病
其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院
诊断影像中心
门诊手术中心 (ASC)
其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

Canon Inc.
Carestream Health
CHISON Medical Technologies Co., Ltd.
Esaote SPA
FUJIFILM Holdings Corporation
GE HealthCare Technologies Inc.
Koninklijke Philips N.V.
Neusoft Corporation
Samsung Electronics Co., Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shimadzu Corporation
Siemens Healthineers AG
Ziehm Imaging GmbH

简介目录

Product Code: 11128

The Global Coronary Heart Disease Diagnostic Imaging Devices Market share recorded USD 1.8 billion in 2022 and will exhibit a growth rate of 6.6% between 2024 and 2032, fueled by the increasing prevalence of coronary heart disease (CHD) and the growing demand for early diagnosis and prevention. As CHD rates rise globally, there is a heightened need for advanced imaging technologies to detect the condition at early stages. Early diagnosis allows for timely intervention, reducing the risk of severe outcomes. This focus on proactive healthcare drives demand for sophisticated diagnostic imaging devices, thereby expanding the market as healthcare systems prioritize effective and early detection solutions.

The overall coronary heart disease diagnostic imaging devices industry is segmented based on modality, application, end-use, and region.

The computed tomography (CT) segment will accumulate USD 443.8 million by 2032 due to its superior imaging capabilities and precision. CT scans provide detailed cross-sectional images of the heart and blood vessels, enabling accurate diagnosis of coronary artery disease and assessment of plaque buildup. The technology's ability to quickly produce high-resolution images makes it a preferred choice for clinicians seeking reliable and efficient diagnostic tools. As demand for detailed cardiac imaging increases, the CT segment will dominate the market.

The heart attack segment captured USD 585.7 million in 2023, attributed to the critical need for rapid and accurate diagnosis in acute scenarios. Timely identification of heart attacks is crucial for effective treatment and improved patient outcomes. Diagnostic imaging devices, such as CT and MRI, play a key role in assessing the extent of heart damage and guiding interventions. As the prevalence of heart attacks continues to rise, the demand for advanced imaging solutions in this segment will drive significant market growth.

The U.S. coronary heart disease diagnostic imaging devices market will reach USD 1.3 billion by 2032, owing to its advanced healthcare infrastructure, high prevalence of coronary heart disease, and substantial investments in medical technology. The country's robust healthcare system and high adoption rates of cutting-edge diagnostic tools, including advanced imaging technologies, drive market growth. Additionally, the U.S. benefits from ongoing research and development efforts, making it a key contributor to the expansion and innovation in the coronary heart disease diagnostic imaging devices industry.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of coronary heart disease
  - 3.2.1.2 Advancements in diagnostic imaging technology
  - 3.2.1.3 Growing awareness and early diagnosis of coronary heart disease
  - 3.2.1.4 Growing demand for non-invasive diagnostic tools
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of imaging devices
  - 3.2.2.2 Lack of skilled professionals
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Gap analysis
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Modality, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Computed tomography (CT)
5.3 X-ray
5.4 Ultrasound
5.5 Magnetic resonance imaging(MRI)
5.6 Nuclear medicine

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Arrhythmia
6.3 Heart attack
6.4 Heart failure
6.5 Congenital heart conditions
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Diagnostic imaging centers
7.4 Ambulatory surgical centers (ASCs)
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa